Sorcero
Sorcero is a Washington, D.C.-based AI platform that delivers medically-tuned Agentic AI and data intelligence to global pharmaceutical, biotech, and medical device companies. It unifies 250M+ scientific publications and structured data into traceable insights for medical affairs, scientific communications, pharmacovigilance, and field medical workflows.
- Company typePrivate
- Founded2018
- HeadquartersWashington, United States
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What Sorcero does
Sorcero, Inc. is a Washington, D.C.-based AI and data intelligence company founded in 2018 that builds a medically-tuned Agentic AI platform for the life sciences industry. The platform combines natural language processing with 1,000+ domain-specific biomedical ontologies to unify structured and unstructured data — including a Scientific Data Pool of 250M+ publications and 3.5M congress abstracts from 4,300+ global conferences — and produces traceable, evidence-grounded insights for medical affairs, scientific communications, pharmacovigilance, and medical device teams. The product is sold across three suites — Sorcero Medical™, Sorcero SciComms™, and Sorcero Safety™ — with adjunct solutions such as Field Medical Excellence & Insights, Congress Intelligence, Publication Intelligence, and the Therapy Resonance Profile.
The company operates an enterprise SaaS model sold primarily through direct high-touch field sales to global pharmaceutical companies, paired with dedicated Insights Leads, Deployment Strategists, and implementation services. Distribution channels include direct enterprise contracting (via procurement portals Ariba, Coupa, Jaggaer), the Google Cloud Marketplace, and the NIH Carahsoft STRIDES Initiative for public-sector buyers, with a native Sorcero Capture App on iPad/iPhone supporting field MSL workflows. Sorcero has raised $59M across a 2021 Series A and a 2025 Series B led by NewSpring Growth, acquired Axiom Health in 2025 to extend into medical devices, and reports penetration of approximately 40% of the top 30 global pharmaceutical companies. Certifications include SOC 2 Type II, ISO 27001, GDPR, DPF, and B Corporation status, with regulatory-grade performance benchmarks (99.83% sensitivity, 96.1% accuracy) supported by peer-reviewed validation studies in journals including JAMIA Open.
Sorcero firmographics
Firmographics- Name
- Sorcero
- Legal name
- Sorcero, Inc.
- Website
- https://sorcero.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Sorcero is a Washington, D.C.-based AI platform that delivers medically-tuned Agentic AI and data intelligence to global pharmaceutical, biotech, and medical device companies. It unifies 250M+ scientific publications and structured data into traceable insights for medical affairs, scientific communications, pharmacovigilance, and field medical workflows.
- Ownership category
- akta.pro rank
Sorcero industry classification
Industry- Product category
- Life Sciences AI Intelligence Platform
- NAICS
- Software Publishers (5132)
- akta.pro primary industry
- Knowledge Management & Scientific Collaboration / Literature Intelligence (HLAGAJAN)
- akta.pro secondary industries
- Pharmacovigilance & Drug Safety Software (HLAGAJAK), Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D) (HLAGAJAC), AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO)
Keywords
Where Sorcero is headquartered
LocationHeadquarters
- HQ city
- Washington
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Sorcero business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- SaaS Platform Subscription: Sorcero operates as a SaaS platform sold to enterprise life sciences organizations on a subscription basis, with enterprise contracts typically involving multi-year terms, dedicated implementation services, and platform licensing fees. The company pairs its platform with high-touch services including Insights Leads and Deployment Strategists to drive organizational alignment and adoption.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise SaaS platform with tiered product suites (Medical, SciComms, Safety) |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels9 records
Sorcero product offering
Product offeringCore offering
Sorcero builds and sells a medically-tuned Agentic AI platform for life sciences organizations that unifies structured and unstructured medical evidence from publications, congresses, CRM notes, and internal data into traceable, actionable insights. The platform is delivered through three product suites — Sorcero Medical™, Sorcero SciComms™, and Sorcero Safety™ — and is sold as an enterprise SaaS subscription with high-touch implementation services targeting global pharmaceutical, biotech, and medical device companies.
Product overview
Sorcero offers a unified AI intelligence platform for life sciences with three main product suites: Sorcero Medical™ (for medical affairs strategy and insights), Sorcero SciComms™ (for scientific content generation and publication intelligence), and Sorcero Safety™ (for pharmacovigilance and literature monitoring). The platform is powered by the Sorcero Intelligence Platform which unifies data from disparate sources and leverages medically-tuned Agentic AI. Key solutions include Medical Insights Management, Field Medical Excellence & Insights, Congress Intelligence, Publication Intelligence, Scientific Content Generation, Literature Monitoring, and Safety Insights. The platform features include the Instant Insights Engine, Scientific Sentiment™, Intelligent Medical Themes™, and the Scientific Data Pool. Sorcero acquired Axiom Health in 2025 to expand into medical devices.
Differentiator
Problem solved
Functional benefit
Brands
- Sorcero Medical™: Transforms fragmented data into unified, actionable intelligence for medical affairs teams, shifting scientific exchange from manual to strategic.
- Sorcero SciComms™
- Sorcero Safety™
- Sorcero Intelligence Platform™
- Sorcero Capture App™
Products and services
- Sorcero Intelligence Platform
Quantifiable outcome
- 72% reduction in medical data analysis time
- +11 more outcomes
Companies that use Sorcero
Customer profileNamed customers21 records
Segments6 records
Ideal customer profiles5 records
Sorcero technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration4 records
AI capability10 records
Feature11 records
Sorcero partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered major, core, growing and significant.
- Google CloudmajorSorcero is hosted on Google Cloud Platform (carbon-neutral hosting) and serves as a Google Cloud partner, having been named Google Cloud's Partner of the Year for Healthcare & Life Sciences. The partnership includes co-authoring a whitepaper on Responsible AI for Life Sciences with Google and USDM Life Sciences. Available via Google Cloud Marketplace.
- SnowflakecoreSnowflake is listed as a technology partner with a growing ecosystem relationship. Sorcero integrates with customer Snowflake data stores as part of its enterprise data integration capabilities.
- DatabrickscoreDatabricks is listed as a technology partner within Sorcero's growing ecosystem. Sorcero integrates with customer Databricks data stores for enterprise data integration.
- Komodo HealthgrowingKomodo Health is listed as part of Sorcero's growing ecosystem of data and technology partners.
- The Lockwood GroupgrowingThe Lockwood Group is listed as part of Sorcero's growing ecosystem of data and technology partners, serving medical communications needs.
- USDM Life SciencescoreSorcero partnered with USDM Life Sciences and Google to co-author 'A Comprehensive Guide to Responsible AI for Life Sciences' whitepaper. USDM provides expertise in life sciences AI compliance and validation frameworks, shaping Sorcero's approach to regulatory-grade AI deployment.
- Medical Affairs Professional Society (MAPS)majorSorcero partnered with MAPS (Medical Affairs Professional Society) to co-author the 'Medical Insights Transformation in the Age of AI' whitepaper, sponsors MAPS Americas 2026 conference (Booth #126, Field Medical Masterclass), and hosts joint webinars featuring industry leaders from pharma and biotech companies.
- LumanitycoreLumanity collaborated with Sorcero and UCB on a published study demonstrating that bespoke AI tooling significantly reduces time and effort for professional medical writers developing Plain Language Summary abstracts. Research was published in JAMIA Open in April 2025.
- NIH / CarahsoftsignificantSorcero is available via the NIH Carahsoft STRIDES Initiative on Google Cloud, simplifying procurement for government and academic institutions. This partnership enables public sector and academic buyers to purchase Sorcero through established government contracting vehicles.
- MSL MasterygrowingMSL Mastery (co-founded by Patrina Pellett, Ph.D. and Sarah Snyder, PharmD) co-hosted a Sorcero-MAPS webinar on AI reshaping MSL-HCP engagement. Patrina developed an automated 'email digest agent' tool featured in the webinar discussion.
Scale indicators13 records
Recent moves6 records
Expansion highlights6 records
Sorcero competitors and assessment
Company assessmentMarket position
Competitive moat6 records
Key highlights7 records
Customer concentration
Sorcero social profiles
Digital presenceSorcero compliance and trust
Trust signalCompliance5 records
Sorcero financial estimates
Financial estimateRevenue estimate
Valuation estimate
Sorcero leadership team
Management profileNumber of profiles
Profiles10 records
Sorcero subsidiaries and ownership
Company hierarchySubsidiaries1 record
Sorcero funding detail
Funding detailFunding overview
Funding rounds9 records
Investors16 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Sorcero M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Sorcero
What does Sorcero do?
Sorcero builds and sells a medically-tuned Agentic AI platform for life sciences organizations that unifies structured and unstructured medical evidence from publications, congresses, CRM notes, and internal data into traceable, actionable insights. The platform is delivered through three product suites — Sorcero Medical™, Sorcero SciComms™, and Sorcero Safety™ — and is sold as an enterprise SaaS subscription with high-touch implementation services targeting global pharmaceutical, biotech, and medical device companies.
Is Sorcero a public or private company?
Sorcero is a private company. It is classified as venture growth investor backed and is currently operating.
When was Sorcero founded?
Sorcero was founded in 2018. It employs 51 to 100 people.
Where is Sorcero based?
Sorcero is headquartered in Washington, United States, in the North America region.
How does Sorcero make money?
One revenue line is on record: saaS Platform Subscription.
Does Sorcero have an API?
No public API is recorded for Sorcero.
What industry is Sorcero in?
Sorcero's product category is Life Sciences AI Intelligence Platform. Its primary akta.pro industry code is HLAGAJAN, Knowledge Management & Scientific Collaboration / Literature Intelligence, with a secondary code of HLAGAJAK, Pharmacovigilance & Drug Safety Software. Its NAICS code is 5132.